Literature DB >> 2760465

A simple method for the biochemical purification of Ro/SS-A antigen.

D H Wu1, A Tavoni, C Garzelli, R Neri, C Vitali, S Bombardieri.   

Abstract

In the present study, Ro/SS-A antigen has been isolated from human spleen by a two-step procedure. In the first step most of the non-antigenic material was removed by means of ammonium sulphate precipitation and ion exchange chromatography. The final purification was obtained by passing the Ro/SS-A-containing fractions twice through a Mono Q ion exchange fast protein liquid chromatography (FPLC) column. The purified antigen showed identical immunoreactivity with crude material on CIE and was composed of two polypeptides with a molecular weight of approximately 60,000 and 55,000 respectively on SDS-PAGE, both reacting on Western blotting with a panel of anti-Ro/SS-A antisera. This system permits milligrams of highly purified antigen to be obtained from grams of human spleen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760465     DOI: 10.1016/0022-1759(89)90163-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

Review 1.  Autoantibodies against small cytoplasmic ribonucleoproteins: the anti-Ro/SS-A and anti-La/SS-B autoimmune response. A review of autoantibody detection, autoantigen composition, autoantibody-disease associations and possible etiologic mechanisms.

Authors:  J F Meilof
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Affinity-based separations and purifications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1991-01       Impact factor: 2.926

3.  Structure and homology of human C1q receptor (collectin receptor).

Authors:  R Malhotra; A C Willis; J C Jensenius; J Jackson; R B Sim
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

4.  A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera.

Authors:  J Lu; A C Willis; R B Sim
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.